KentHoskinsMD

Summary

• Kent Hoskins, MD, is a Chicago-based, board certified medical oncologist with sub-specialty expertise in breast cancer and cancer genetics/cancer risk assessment. His education includes residencies in Internal Medicine at the University of Iowa Hospitals and Clinics and a Fellowship in Hematology and Medical Oncology at the University of Michigan. He is the Eileen Lindsay Heidrick Professor in Oncology and Professor of Medicine in the Division of Hematology/Oncology at the University of Illinois College of Medicine, where he has been since 2012. He also serves as Associate Chief in the Hematology/Oncology Division and the Medical Director for the Oncology Service Line at the University of Illinois Health System/University of Illinois Cancer Center. His areas of expertise include breast cancer, clinical cancer genetics, and breast cancer risk assessment and prevention. He also consistently publishes research and is involved in clinical trials, with notable studies addressing topics such as Tamoxifen dose for breast cancer risk reduction, social and biological determinants of breast cancer disparities, and genetic counseling uptake among African American women.